Treatment of experimental haemorrhagic shock in dogs.
D000818:Animals; D001158:Arteries; D001794:Blood Pressure; D001810:Blood Volume; D002245:Carbon Dioxide / Q000097:blood; D003911:Dextrans / Q000494:pharmacology / Q000627:therapeutic use*; D004285:Dogs; D005780:Gelatin / Q000627:therapeutic use*; D006400:Hematocrit; D006454:Hemoglobins; D006470:Hemorrhage / Q000188:drug therapy*; D006863:Hydrogen-Ion Concentration; D007263:Infusions, Parenteral; D010100:Oxygen / Q000097:blood; D010952:Plasma Substitutes / Q000627:therapeutic use*; D012771:Shock, Hemorrhagic / Q000097:blood / Q000188:drug therapy*; D013997:Time Factors; D014680:Veins
D003911:Dextrans; D006454:Hemoglobins; D010952:Plasma Substitutes; D002245:Carbon Dioxide; D005780:Gelatin; D010100:Oxygen